VANGUARD GROUP INC 13D and 13G filings for 4D Molecular Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 12:12 pm Unchanged |
2024-09-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
VANGUARD GROUP INC | 2,767,717 5.320% |
0 (Unchanged) |
Filing |
| 2024-11-04 10:55 am Purchase |
2024-09-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
VANGUARD GROUP INC | 2,767,717 5.320% |
2,767,717 (New Position) |
Filing |